Article Contents
- 2023 (Vol.86)
- 2022 (Vol.85)
- 2021 (Vol.84)
- 2020 (Vol.83)
- 2019 (Vol.82)
- 2018 (Vol.81)
- 2017 (Vol.80)
- 2016 (Vol.79)
- 2015 (Vol.78)
- 2014 (Vol.76)
- 2013 (Vol.74)
- 2012 (Vol.72)
- 2011 (Vol.70)
- 2010 (Vol.68)
- 2009 (Vol.66)
- 2008 (Vol.64)
- 2007 (Vol.62)
- 2006 (Vol.60)
- 2005 (Vol.58)
- 2004 (Vol.56)
- 2003 (Vol.54)
- 2002 (Vol.52)
Clinical Study of Topotecan as Second-Line Treatment in Small Cell Lung Cancer
Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2002, v.52 no.3, pp.230-240
&
(2002). Clinical Study of Topotecan as Second-Line Treatment in Small Cell Lung Cancer. Tuberculosis & Respiratory Diseases, 52(3), 230-240.
- Downloaded
- Viewed
Abstract
- keywords
- Downloaded
- Viewed
- 0KCI Citations
- 0WOS Citations